Crop Life Science Ltd (CLSL) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Crop Life Science Ltd reported sales of ₹87 Cr, operating profit of ₹10 Cr (OPM 11%) and net profit of ₹4 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
CLSL quarterly results (₹ Cr) Metric Sep 2023 Sep 2024 Mar 2025 Sep 2025 Mar 2026 Sales 97 106 94 120 87 Expenses 91 98 86 112 77 Operating Profit 6 8 8 8 10 OPM 7% 8% 9% 7% 11% Other Income 1 0 1 1 1 Interest 1 2 2 3 3 Depreciation 2 2 2 2 3 Profit before tax 4 4 4 4 5 Tax 20% 27% 29% 29% 30% Net Profit 3 3 3 3 4 EPS in Rs 1.96 1.83 1.61 1.79 2.09
CLSL profit & loss, annual (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 130 191 196 203 214 Expenses 118 178 180 185 198 Operating Profit 12 13 16 18 16 OPM 9% 7% 8% 9% 7% Other Income 1 2 1 2 2 Interest 3 3 5 5 5 Depreciation 4 3 5 5 5 Profit before tax 6 8 8 9 8 Tax 27% 26% 28% 30% - Net Profit 4 6 6 6 6 EPS in Rs 3.39 3.51 3.44 3.87 3.4 Dividend Payout 0% 0% 0% 0% -
CLSL balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 12 17 17 17 17 Reserves 29 55 60 63 67 Borrowings 27 35 44 58 57 Other Liabilities 34 73 60 81 67 Total Liabilities 102 180 182 220 208 Fixed Assets 16 39 38 30 30 CWIP 0 0 0 0 0 Investments 0 0 1 3 1 Other Assets 86 141 143 187 177 Total Assets 102 180 182 220 208
CLSL cash flows (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 2 -8 -2 -8 Cash from Investing Activity -4 -3 -4 2 Cash from Financing Activity 1 13 -7 -9 Net Cash Flow -2 2 -12 -15 Free Cash Flow -3 -13 -5 -4 CFO/OP 34% -49% 4% -28%
CLSL ratios Metric Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 92 148 129 134 Inventory Days 104 99 126 170 Days Payable 79 132 114 126 Cash Conversion Cycle 116 115 141 178 Working Capital Days 86 85 90 107 ROCE - 12% 11% 11%